On the other hand, our analysis also showed hypomethylated DMPs for some genes, confirming previous reports showing that upregulated UHRF1/2 could mediate DNMT3A ubiquitination and proteasome-dependent degradation, leading to genome-wide de novo DNA methylation in cancer cells [52, 53]. This evidence concerns the gene DNMT3A and cancer.